Revathi, T. published the artcileSynthesis of novel tetrazolo and triazolo [1,2-e] imidazolo [4,5-b] quinoxaline derivatives as antimicrobial agents, Recommanded Product: 2,3-Dichloro-6-methylquinoxaline, the main research area is quinoxaline imidazolo preparation antibacterial antifungal activity; dichloroquinoxaline amine heterocyclization potassium carbonate catalyst.
An efficient general method has been described for the synthesis of novel tetrazolo and triazolo[1,2-e]imidazolo[4,5-b]quinoxaline derivatives I (R1 = R2 = H, CH3; R1 = NO2, Br, Cl) and II by the reaction of (1H)-tetrazol-5-amine and (3H)-1,2,3-triazol-4-amine with substituted 2,3-dichloroquinoxaline in DMF solvent and added a catalytic amount of K2CO3. The synthesized compounds I and II were evaluated for their antimicrobial activity against Bacillus subtilis, Staphylococcus aureus (Gram pos. bacteria), Escherichia coli (Gram Neg. bacteria) and Aspergillus niger, Candida albicans (fungi). The quinoxalines I [R1 = NO2, Cl; R2 = H] and II [R1 = NO2, Cl; R2 = H] were identified as potent antimicrobial agents.
World Journal of Pharmaceutical Research published new progress about Antibacterial agents. 39267-05-5 belongs to class quinoxaline, name is 2,3-Dichloro-6-methylquinoxaline, and the molecular formula is C9H6Cl2N2, Recommanded Product: 2,3-Dichloro-6-methylquinoxaline.
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider